|
BY51680 |
(Z)-ethyl 2-(2,4-dioxo-5-(2-(2-oxo-2-(phenylamino)ethoxy)benzylidene)thiazolidin-3-yl)acetate |
444072-13-3 |
C22H20N2O6S |
440.4690 |
VIEW DETAILS > |
|
BU44790 |
(E)-2-(5-((1-(4-methoxyphenyl)-1H-pyrrol-2-yl)methylene)-4-oxo-2-thioxothiazolidin-3-yl)acetic acid |
444072-16-6 |
C17H14N2O4S2 |
374.4341 |
VIEW DETAILS > |
|
BX72676 |
(E)-2-cyano-N-(3-methoxyphenyl)-3-(1-propan-2-ylindol-3-yl)prop-2-enamide |
444072-49-5 |
C22H21N3O2 |
359.4210 |
VIEW DETAILS > |
|
BW86290 |
N-[(E)-(2-chloro-5-nitrophenyl)methylideneamino]-2-(9-oxoacridin-10-yl)acetamide |
444072-67-7 |
C22H15ClN4O4 |
434.8319 |
VIEW DETAILS > |
|
BY47719 |
(5Z)-5-[[4-[(3,4-dichlorophenyl)methoxy]-3-iodophenyl]methylidene]-1-(4-fluorophenyl)-2-sulfanylidene-1,3-diazinane-4,6-dione |
444072-76-8 |
C24H14Cl2FIN2O3S |
627.2534 |
VIEW DETAILS > |
|
BT87055 |
(Z)-7-(4-bromophenyl)-10-(thiophen-2-ylmethylene)-7,10-dihydro-5H-benzo[h]thiazolo[2,3-b]quinazolin-9(6H)-one |
444072-89-3 |
C25H17BrN2OS2 |
505.4493 |
VIEW DETAILS > |
|
BX39569 |
(5E)-5-[(3-ethoxy-4-hydroxy-5-prop-2-enylphenyl)methylidene]-2-(4-methylanilino)-1,3-thiazol-4-one |
444072-90-6 |
C22H22N2O3S |
394.4867 |
VIEW DETAILS > |
|
BV31120 |
(5E)-5-[[1-(2-ethyl-6-methylphenyl)-2,5-dimethylpyrrol-3-yl]methylidene]-1-methyl-2-sulfanylidene-1,3-diazinane-4,6-dione |
444072-97-3 |
C21H23N3O2S |
381.4912 |
VIEW DETAILS > |
|
BW01996 |
(Z)-ethyl 2-(5-(3-bromo-5-methoxy-4-((3-nitrobenzyl)oxy)benzylidene)-2,4-dioxothiazolidin-3-yl)acetate |
444073-01-2 |
C22H19BrN2O8S |
551.3639 |
VIEW DETAILS > |
|
AX52692 |
(D-Ala2)-Gastric Inhibitory Polypeptide (human) trifluoroacetate salt H-Tyr-D-Ala-Glu-Gly-Thr-Phe-Ile-Ser-Asp-Tyr-Ser-Ile-Ala-Met-Asp-Lys-Ile-His-Gln-Gln-Asp-Phe-Val-Asn-Trp-Leu-Leu-Ala-Gln-Lys-Gly-Lys-Lys-Asn-Asp-Trp-Lys-His-Asn-Ile-Thr-Gln-OH trifluoroacetate salt |
444073-04-5 |
C226H338N60O66S |
4983.5293 |
VIEW DETAILS > |